Sickle Cell Disease - Stroke Prevention in Nigeria Trial

NCT01801423 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

29

Enrollment

OTHER

Sponsor class

Conditions

Sickle Cell Anemia
Sickle Cell Disease
Stroke

Interventions

DRUG: Hydroxyurea

Sponsor

Vanderbilt University Medical Center

Collaborators

[object Object]
[object Object]
[object Object]